已收盘 04-15 16:00:00 美东时间
0.000
0.00%
Cardiff Oncology announced leadership changes amid its growth phase. CEO Mark Erlander and CFO James Levine have stepped down, with Dr. Mani Mohindru, a board member, appointed interim CEO. The company seeks permanent replacements for both roles. Cardiff's lead product, onvansertib, a PLK1 inhibitor, is in mid-stage trials for RAS-mutated colorectal cancer and being evaluated in other cancers. Dr. Mohindru brings extensive biotech experience and ...
01-27 12:00
An update from Carasent AB ( ($SE:CARA) ) is now available. Carasent AB has ann...
2025-07-10 01:32
Tvardi advances fibrosis drug TTI-101 in IPF and liver cancer as Piper initiates with $78 target; merger boosts cash runway into late 2026.
2025-06-13 03:08
GAINERS: CLS Holdings USA (OTC:CLSH) shares closed up 12.00% at $0.03 Cipher P...
2025-04-16 04:30
The latest announcement is out from Cara Therapeutics ( ($CARA) ). On December ...
2025-04-12 04:47
Diagnos ( ($TSE:ADK) ) has issued an announcement. Diagnos Inc. has announced t...
2025-04-09 19:04
GAINERS: Elixinol Wellness (OTC:ELLXF) shares closed up 30.62% at $0.02 Maple ...
2025-04-05 04:30
GAINERS: Elixinol Wellness (OTC:ELLXF) shares closed up 235.83% at $0.04 1933 ...
2025-03-21 04:30
NEW YORK, Feb. 21, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2025-02-22 01:02